Prisons don’t get listed on exposure sites, but are among the the sites with active cases of 5 or more (Ravenhall and Parkville juvie).
High case numbers in NSW prisons, hard cell lockdowns.
Now an outbreak reported in a Melbourne prison.
Journos don’t get around to asking about vax programs for prisoners.
We’re trying to be ‘efficient’ by using every test and all the results focussed on people with symptoms.
By widening the test criterior, you find some of those mystery cases. It doesn’t mean you identify them (as in the chains of infections) but you do end up finding them.
I wouldn’t be surprised if a good percentage of the 38k cases under investigation end up being genetically linked (even if they aren’t epidemiologically linked).
Not that this surprises. You can take it to the bank that boosters will be required within 6 months.
The effectiveness of the Pfizer Inc (PFE.N)/BioNTech SE vaccine in preventing infection by the coronavirus dropped to 47% from 88% six months after the second dose, according to data published on Monday that U.S. health agencies considered when deciding on the need for booster shots.
The data suggests that the drop is due to waning efficacy, rather than more contagious variants, researchers said.
Vaccine effectiveness against the Delta variant was 93% after the first month, declining to 53% after four months. Against other coronavirus variants, efficacy declined to 67% from 97%.
Do you know of the workplace sectors in Victoria subject to mandatory testing?
In terms of effectiveness as a control measure, it would be useful to compare the Victorian and NSW sectors subject to mandatory testing ( in addition to those by individual employers)
IiRC there was something in the most recent ATAGI advice about additional shots in December, with enough supplies
but need to distinguish between boosters for the general population and third dose for special categories ( older, health compromised, as in UK and US authorised approvals).
There could be some political elements in decisions at government levels re boosters
WHO concerns when so many low income countries have extremely low vax rates.
Nature published a study back in August, the drop off for Pfizer wasn’t anywhere near as dramatic, but they only went out to 90 days.
AZ started at a lower base, but the drop off in effectiveness was smaller.
Son just had his 1st Moderna. Does anyone know if the 1st or 2nd is more common for side effects. Hoping for minimal reaction or second dose becomes harder to sell. I told him Moderna is less likely to need a booster in 6 months even though I’m not sure if that’s in any way true. I thought I read something about that here. He’s very scared of needles.
Also noting that with any six month survey you need to ask whether resistance has faded to what existed then, or whether it’s mostly Delta being more transmissible.
My wife and I had Moderna, our personal experience was 2nd dose was worse but seems to vary. The second dose made me feel really miserable for just over 24 hours but after that I felt perfectly ok. My wife fared much better, she didn’t find the 2nd dose too bad, although it was a bit worse than her first dose.
That only looked at antibody levels IIRC. Other defences, like AZ’s T cell response, were not considered. Other posters would know way more than me on this …
I think the vax rates have been good across all age groups. 12-18yo were vax eligible in June. Currently it is Pfizer for 12-17yo. No approved vaxxes for under 12.
Pfizer and Moderna are the ones approved for the govt mass vax program for 18yo+. Sinovac and Sinopharm are also allowed at some private clinics, you have to pay for those.